Cite
MLA Citation
Robert Croop et al.. “Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.” Lancet, vol. 394, no. 10200, 2019, pp. 737–745. http://access.bl.uk/ark:/81055/vdc_100091257317.0x00004e